title: The Society of Thoracic Surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary).
authors.affiliation: University of Kentucky Chandler Medical Center, Lexington, Kentucky 40536, USA. ferraris@earthlink.net
authors.forename: Victor A
authors.initials: VA
authors.lastname: Ferraris
authors.forename: Suellen P
authors.initials: SP
authors.lastname: Ferraris
authors.forename: David J
authors.initials: DJ
authors.lastname: Moliterno
authors.forename: Philip
authors.initials: P
authors.lastname: Camp
authors.forename: Jeanine M
authors.initials: JM
authors.lastname: Walenga
authors.forename: Harry L
authors.initials: HL
authors.lastname: Messmore
authors.forename: Walter P
authors.initials: WP
authors.lastname: Jeske
authors.forename: Fred H
authors.initials: FH
authors.lastname: Edwards
authors.forename: David
authors.initials: D
authors.lastname: Royston
authors.forename: David M
authors.initials: DM
authors.lastname: Shahian
authors.forename: Eric
authors.initials: E
authors.lastname: Peterson
authors.forename: Charles R
authors.initials: CR
authors.lastname: Bridges
authors.forename: George
authors.initials: G
authors.lastname: Despotis
mesh_terms: D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use*; D001026:Coronary Artery Bypass; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D019106:Postoperative Hemorrhage / Q000209:etiology
chemical_list: D010975:Platelet Aggregation Inhibitors; D001241:Aspirin